BioPharma Credit PLC (BOPCF)
BioPharma Credit PLC operates in the Asset Management industry of the Financial Services sector, headquartered in London, GL, GB. The stock last traded at $0.99, up 67915194.00% on the session, giving a market capitalisation of $1.11B. On trailing twelve-month figures it carries a trailing P/E of 8.48, a net margin of 92.6%. Its beta of 0.10 implies it has historically moved less than the broad market.
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
BioPharma Credit PLC is most often compared with the following Financial Services names: